Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Filings indexed 371 across all filing types
Latest filing 2023-12-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It includes a formal amendment (정정신고) to the payment date and listing date of new shares. This type of filing relates to capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-12-22 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically details a correction (정정신고) to the payment date and related terms. In the context of Korean corporate filings (DART), this is a regulatory announcement regarding capital structure changes and financing activities. Since it specifically details the issuance and terms of convertible bonds, it falls under the 'Capital/Financing Update' category.
2023-12-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of regulatory filing is required when an individual or entity acquires a significant stake (typically 5% or more) in a publicly traded company, often involving changes in management control or major shareholding status. Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2023-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal notice of the upcoming meeting process. Given the nature of the announcement and the lack of a specific category for 'Record Date' notices, it falls under the general regulatory filing category.
2023-12-14 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Jeonjin BioPharm) regarding a 'Change in Largest Shareholder' via a stock purchase agreement. It is a formal amendment (정정신고) to a previous disclosure, detailing changes in payment dates and share transfer schedules. This type of corporate disclosure regarding ownership structure and major shareholding changes falls under the category of 'Major Shareholding Notification' (MRQ) as it pertains to the transfer of control and significant shareholding thresholds.
2023-12-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Woo Sang-hyun) of Jeonjin Bio-Pharm. This type of filing is a standard regulatory requirement for reporting insider transactions (director's dealings) in South Korea. Based on the provided definitions, this falls under 'Director's Dealing'.
2023-12-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.